U.S. markets closed
  • S&P Futures

    4,436.50
    -38.25 (-0.85%)
     
  • Dow Futures

    34,431.00
    -185.00 (-0.53%)
     
  • Nasdaq Futures

    14,637.50
    -203.50 (-1.37%)
     
  • Russell 2000 Futures

    2,007.40
    -13.80 (-0.68%)
     
  • Crude Oil

    86.29
    -0.61 (-0.70%)
     
  • Gold

    1,841.30
    -1.30 (-0.07%)
     
  • Silver

    24.44
    -0.28 (-1.12%)
     
  • EUR/USD

    1.1331
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    1.8330
    +0.0060 (+0.33%)
     
  • Vix

    25.59
    +1.74 (+7.30%)
     
  • GBP/USD

    1.3595
    -0.0005 (-0.03%)
     
  • USD/JPY

    113.7250
    -0.3750 (-0.33%)
     
  • BTC-USD

    39,658.18
    -2,336.14 (-5.56%)
     
  • CMC Crypto 200

    932.30
    -62.96 (-6.33%)
     
  • FTSE 100

    7,585.01
    -4.65 (-0.06%)
     
  • Nikkei 225

    27,377.44
    -395.49 (-1.42%)
     

Baxter Recalls Dose IQ Software 9.0.x Used With Infusion Pumps

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • BAX
  • The FDA issued a Class I recall, the most serious kind of recall, for Baxter International Inc's (NYSE: BAX) Dose IQ safety software used with Spectrum IQ Infusion System.

  • The Dose IQ safety software allows care providers to create a drug library of pre-programmed dosing information for specific medications delivered into a person's body in controlled amounts using the Spectrum IQ infusion pump.

  • The recall occurred due to a software defect that may lead to mismatched drug information in drug libraries created using version 9.0.x of the computer-based software.

  • If the software's drug identifier does not match the drug information on the pump, it will lead to improper drug configuration and causing a delay in therapy, under-infusion, or over-infusion of medication.

  • There have been 15 complaints, no injuries, and no deaths reported for the issue.

  • In total, Baxter Healthcare recalled 61 devices since initiating the recall on July 7, 2021.

  • Price Action: BAX shares closed lower by 0.16% at $73.86 on Thursday.

  • Related content: Benzinga's Full FDA Calendar.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.